Skip to main content

Want a detailed portfolio tracker?

HQL
NYSE
$19.54

abrdn Life Sciences Investors (HQL)

Net assets

$689M

Sharpe Ratio

2.31

Price Chart

Valuation
Net assets$689M
Growth & Risk
Dividends 5Y CAGR+9.07%
Beta (5Y)0.71
Sharpe Ratio2.31